Literature DB >> 22462724

Identification of protein targets of reactive metabolites of tienilic acid in human hepatocytes.

Yakov M Koen1, Diganta Sarma, Todd D Williams, Nadezhda A Galeva, R Scott Obach, Robert P Hanzlik.   

Abstract

Tienilic acid (TA) is a uricosuric diuretic that was withdrawn from the market only months after its introduction because of reports of serious incidents of drug-induced liver injury including some fatalities. Its hepatotoxicity is considered to be primarily immunoallergic in nature. Like other thiophene compounds, TA undergoes biotransformation to a S-oxide metabolite which then reacts covalently with cellular proteins. To identify protein targets of TA metabolites, we incubated [(14)C]-TA with human hepatocytes, separated cellular proteins by 2D gel electrophoresis, and analyzed proteins in 36 radioactive spots by tryptic digestion followed by LC-MS/MS. Thirty-one spots contained at least one identifiable protein. Sixteen spots contained only one of 14 nonredundant proteins which were thus considered to be targets of TA metabolites. Six of the 14 were also found in other radioactive spots that contained from 1 to 3 additional proteins. Eight of the 14 had not been reported to be targets for any reactive metabolite other than TA. The other 15 spots each contained from 2 to 4 identifiable proteins, many of which are known targets of other chemically reactive metabolites, but since adducted peptides were not observed, the identity of the adducted protein(s) in these spots is ambiguous. Interestingly, all the radioactive spots corresponded to proteins of low abundance, while many highly abundant proteins in the mixture showed no radioactivity. Furthermore, of approximately 16 previously reported protein targets of TA in rat liver ( Methogo, R., Dansette, P., and Klarskov, K. ( 2007 ) Int. J. Mass Spectrom. , 268 , 284 -295 ), only one (fumarylacetoacetase) is among the 14 targets identified in this work. One reason for this difference may be statistical, given that each study identified a small number of targets from among thousands present in hepatocytes. Another may be the species difference (i.e., rat vs human), and still another may be the method of detection of adducted proteins (i.e., Western blot vs C-14). Knowledge of human target proteins is very limited. Of more than 350 known protein targets of reactive metabolites, only 42 are known from humans, and only 21 of these are known to be targets for more than one chemical. Nevertheless, the demonstration that human target proteins can be identified using isolated hepatocytes in vitro should enable the question of species differences to be addressed more fully in the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22462724      PMCID: PMC3358484          DOI: 10.1021/tx300103j

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  63 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite isomer.

Authors:  Patrick M Dansette; Julien Rosi; Gildas Bertho; Daniel Mansuy
Journal:  Chem Res Toxicol       Date:  2011-12-01       Impact factor: 3.739

3.  Structure and stereochemistry of the active metabolite of clopidogrel.

Authors:  Jean-Marie Pereillo; Mohamed Maftouh; Alain Andrieu; Marie-Francoise Uzabiaga; Olivier Fedeli; Pierre Savi; Marc Pascal; Jean-Marc Herbert; Jean-Pierre Maffrand; Claudine Picard
Journal:  Drug Metab Dispos       Date:  2002-11       Impact factor: 3.922

4.  Identification of seven proteins in the endoplasmic reticulum as targets for reactive metabolites of bromobenzene.

Authors:  Yakov M Koen; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2002-05       Impact factor: 3.739

5.  Identification of three protein targets for reactive metabolites of bromobenzene in rat liver cytosol.

Authors:  Y M Koen; T D Williams; R P Hanzlik
Journal:  Chem Res Toxicol       Date:  2000-12       Impact factor: 3.739

6.  Effects of ticrynafen on hepatic excretory function in the isolated perfused rat liver.

Authors:  H J Zimmerman; C O Abernathy; L Lukacs; M Ezekiel
Journal:  Hepatology       Date:  1982 Mar-Apr       Impact factor: 17.425

Review 7.  Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.

Authors:  David C Evans; Alan P Watt; Deborah A Nicoll-Griffith; Thomas A Baillie
Journal:  Chem Res Toxicol       Date:  2004-01       Impact factor: 3.739

8.  Mechanism-based inactivation of human recombinant P450 2C9 by the nonsteroidal anti-inflammatory drug suprofen.

Authors:  John P O'Donnell; Deepak K Dalvie; Amit S Kalgutkar; R Scott Obach
Journal:  Drug Metab Dispos       Date:  2003-11       Impact factor: 3.922

9.  Comparison of one-dimensional and two-dimensional gel electrophoresis as a separation tool for proteomic analysis of rat liver microsomes: cytochromes P450 and other membrane proteins.

Authors:  Nadezhda Galeva; Michail Altermann
Journal:  Proteomics       Date:  2002-06       Impact factor: 3.984

10.  In vitro metabolism of 2-acetylbenzothiophene: relevance to zileuton hepatotoxicity.

Authors:  Elizabeth M Joshi; Brian H Heasley; Mahendra D Chordia; Timothy L Macdonald
Journal:  Chem Res Toxicol       Date:  2004-02       Impact factor: 3.739

View more
  4 in total

1.  Quantitative Chemical Proteomic Profiling of the in Vivo Targets of Reactive Drug Metabolites.

Authors:  Landon R Whitby; R Scott Obach; Gabriel M Simon; Matthew M Hayward; Benjamin F Cravatt
Journal:  ACS Chem Biol       Date:  2017-06-21       Impact factor: 5.100

2.  Bioactivation of Trimethoprim to Protein-Reactive Metabolites in Human Liver Microsomes.

Authors:  Jennifer L Goldman; Yakov M Koen; Steven A Rogers; Kelin Li; James S Leeder; Robert P Hanzlik
Journal:  Drug Metab Dispos       Date:  2016-07-25       Impact factor: 3.922

3.  Protein targets of thioacetamide metabolites in rat hepatocytes.

Authors:  Yakov M Koen; Diganta Sarma; Heather Hajovsky; Nadezhda A Galeva; Todd D Williams; Jeffrey L Staudinger; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2013-03-20       Impact factor: 3.739

Review 4.  The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity.

Authors:  Volker M Lauschke; Magnus Ingelman-Sundberg
Journal:  Int J Mol Sci       Date:  2016-10-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.